OR WAIT null SECS
Kollicoat MAE 100-55 from BASF can be used as a direct substitute in commercial enteric pharmaceutical formulations.
Kollicoat MAE 100-55, introduced by BASF on April 4, 2016, is a functional excipient for instant and modified release drugs that can replace comparable pH >5.5 enteric release materials in commercial formulations, the company reports. The coating polymer matches the release profile and complies with applicable regulatory monographs and can be used without re-registration.
The size of the dried powder particles delivers dust-free handling, and the product provides equivalent drug release as existing comparable products in the market, according to a company statement.
Kollicoat MAE 100-55 extends the company’s pH >5.5 enteric release coatings based on methacrylic acid-ethylacrylate copolymer.